El Hospital Universitario Clínico San Cecilio es un complejo hospitalario gestionado por el Servicio Andaluz de Salud, ubicado en la ciudad española de Granada.

During the past decade, Hospital Universitario San Cecilio conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 20 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 12 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario San Cecilio" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "MedSIR" with 7 trials sponsored, "Fundación Pública Andaluza para la gestión de la Investigación en Sevilla" with 6 trials sponsored and "Janssen Research & Development, LLC" with 6 trials sponsored. Other sponsors include 94 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario San Cecilio" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Roche Farma, S.A" with 4 trials as a collaborator, "Andaluz Health Service" with 3 trials as a collaborator and "Atrys Health" with 3 trials as a collaborator. Other collaborators include 130 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario San Cecilio" are "Breast Cancer" (9 trials), "Chronic Hepatitis C" (4 trials), "Early Breast Cancer" (4 trials), "HIV Infections" (4 trials) and "HIV" (3 trials). Many other conditions were trialed in "Hospital Universitario San Cecilio" in a lesser frequency.

Most popular intervention types in "Hospital Universitario San Cecilio" are "Drug" (83 trials), "Other" (14 trials), "Biological" (10 trials), "Device" (4 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Fulvestrant" (6 trials), "Abemaciclib" (4 trials), "Anastrozole" (3 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario San Cecilio" are 119 trials for "All" genders, 13 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario San Cecilio". 4 are not yet recruiting, 37 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 65 completed trials in Hospital Universitario San Cecilio, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario San Cecilio, 7 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 9 trials that are defined as “Not Applicable".

Hospital Universitario San Cecilio has several departments that took part in Clinical trials: "Hospital Universitario San Cecilio; Servicio de Oncologia" - 6 trials